Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Pathkey.AI Ltd is a digital health technology company specializing in the development of artificial intelligence-powered tools to enhance clinical trial processes and healthcare research. Its core focus is on building decision-support software designed to improve the efficiency and success rates of clinical trials, streamline protocol design, and deliver actionable market insights for healthcare, MedTech, and life science organizations. Notable products under its portfolio include solutions like TrialKey and TrialGen, which leverage large proprietary datasets and advanced analytics to predict trial outcomes, optimize study protocols, and facilitate patient recruitment through AI and social media technologies. The company's primary clientele includes biopharmaceutical firms, MedTech enterprises, governmental health agencies, and wellness sector clients, who utilize Pathkey.AI Ltd’s platforms to gain deeper insights and speed up the development and delivery of new therapies. With a strong emphasis on the integration of data science, machine learning, and digital health tools, Pathkey.AI Ltd occupies a distinct role in the health information services sector, advancing the digitization and personalization of healthcare research and clinical development.
Select a linked metric to explore its chart.